Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Tetrandrine demonstrates ability to protect against Ebola virus challenge in vivo

Feb. 4, 2014

Sorafenib activity limited in patients with germ cell tumors

Feb. 4, 2014

Pazopanib demonstrates activity in patients with germ cell tumors

Feb. 4, 2014

Evidence of activity seen with MPX in phase I prostate cancer study

Feb. 3, 2014

Radiotracer [18F]VM-4-037 evaluated in phase II renal cancer study

Feb. 3, 2014

Multiple pivotal phase III trials under way at Array BioPharma

Jan. 31, 2014

Clovis Oncology plans big year for 2014

Jan. 31, 2014

Gilead Sciences details outlook for 2014

Jan. 30, 2014

Morphosys provides overview of development pipeline

Jan. 30, 2014

GERD linked to FOXF1 and MHC locus gene polymorphisms

Jan. 29, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...